The global therapeutic clinical nutrition market size was estimated at USD 61.84 billion in 2025 and is predicted to increase from USD 66.76 billion in 2026 to approximately USD 132.89 billion by 2035, expanding at a CAGR of 7.95% from 2026 to 2035. The growth in cancer, diabetes, and metabolic disorders globally is increasing the demand for therapeutic clinical nutrition. Growing health awareness, home care, R&D activities, technological advancements, and new product launches are enhancing the market growth.
The therapeutic clinical nutrition market is driven by the rising geriatric population and increasing chronic disease burden. Therapeutic clinical nutrition refers to the diets and nutritional therapies utilized for the treatment, management, and prevention of diseases. They are used to control and manage diabetes, cancer, hypertension, digestive disorders, and kidney disease.
The use of AI is increasing in the development of therapeutic clinical nutrition products as it helps in developing personalized diet plans and offers nutrition assessment. It also helps in disease prediction, identification of signs of malnutrition, and suggests health and therapeutic diet plans. AI also helps in selecting appropriate nutrition therapies, remote patient monitoring, nutrient tracking, and virtual counseling.
Personalized Nutrition on the Rise
Growing health awareness is increasing the demand for personalized therapeutic clinical nutrition, which is promoting the development of personalized nutrition plans. They are being developed with the patient’s genetic, microbiome analysis, health, and lifestyle data.
Expanding Home Healthcare
A shift towards home healthcare is driving the adoption of home-based therapeutic nutritional services. Additionally, increasing digital health platforms and telehealth nutrition counseling are also increasing their use, promoting smart nutrition tracking and management.
Increasing Medical Foods
The growth in health awareness is increasing the demand for medical food as a preventive healthcare option. This is driving the adoption of probiotics, high-protein formulas, fibre-enriched foods, and immune support nutrients.
| Table | Scope |
| Market Size in 2026 | USD 66.76 Billion |
| Projected Market Size in 2035 | USD 132.89 Billion |
| CAGR (2026 - 2035) | 7.95% |
| Leading Region | North America by 38% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product Type, By Therapeutic Area, By End User, By Ingredient Type, By Application, By Route of Administration, By Age Group, By Distribution Channel, By Region |
| Top Key Players | Abbott Nutrition, B. Braun SE, Nestle Health Science, Ajinomoto Co., Danone (Nutricia), Otsuka Holdings, Fresenius Kabi, Meji Holdings, Baxter International, Reckitt (Mead Johnson) |
| Segment | Share 2025 (%) |
| Oral Clinical Nutrition | 46% |
| Enteral Nutrition | 37% |
| Parenteral Nutrition | 17% |
The Oral Clinical Nutrition Segment Dominated the Market With 46% in 2025
The oral clinical nutrition segment held the largest revenue share of 46% of the therapeutic clinical nutrition market in 2025 and is expected to witness the fastest growth with a CAGR of 8.10% during the forecast period, driven by growth in the preference for convenient nutritional supplementation in outpatient care. Increased chronic disease burden also supported daily therapeutic nutrition adoption. The growth in the elderly population also increased oral nutrition consumption.
The enteral nutrition segment held the second-largest share of 37% of the market in 2025, due to expanding ICU admissions and surgical recovery cases, which increase tube feeding demand. Hospitals are also adopting disease-specific enteral formulas for targeted care. Higher survival rates in critical illness also boost long-term feeding support.
The parenteral nutrition segment held 17% of the therapeutic clinical nutrition market share in 2025, driven by the growing incidence of gastrointestinal dysfunction, which increases intravenous nutrition needs. Advanced hospital infrastructure also supports TPN administration. Rising premature birth rates also drive neonatal parenteral nutrition demand.
| Segment | Share 2025 (%) |
| Oncology Nutrition | 24% |
| Diabetes Management Nutrition | 18% |
| Gastrointestinal Disorders Nutrition | 14% |
| Neurological Disorders Nutrition | 10% |
| Renal Disorders Nutrition | 9% |
| Critical Care Nutrition | 11% |
| Pediatric Clinical Nutrition | 7% |
| Geriatric Nutrition | 7% |
The Oncology Nutrition Segment Dominated the Market With 24% in 2025
The oncology nutrition segment accounted for the highest revenue share of 24% of the therapeutic clinical nutrition market in 2025, due to growth in the global cancer prevalence, which increased demand for cachexia management. Oncology patients required protein-rich clinical nutrition, which increased their use. Hospitals integrate nutritional therapy into cancer care protocols, enhancing their accessibility.
The diabetes management nutrition segment held the second-largest share of 18% of the market in 2025, driven by increasing diabetes prevalence, which accelerates demand for low glycemic formulations. Patients are adopting nutrition therapy for blood sugar stabilization. Clinical guidelines are also increasingly supporting nutritional intervention.
The gastrointestinal disorders nutrition segment held 14% of the therapeutic clinical nutrition market share in 2025, due to the growing incidence of inflammatory bowel diseases, which supports specialized nutrition demand. Malabsorption disorders also require elemental and peptide-based formulas. Gastroenterology clinics are increasingly recommending therapeutic nutrition.
The critical care nutrition segment held 11% of the market share in 2025 and is expected to show the highest growth with a CAGR of 8.80% during the forecast period, due to growing ICU admissions and trauma cases, which increase specialized nutrition requirements. Critical care protocols are also prioritizing early nutritional intervention. High survival rates also increase long-term rehabilitation nutrition demand.
| Segment | Share 2025 (%) |
| Hospitals | 48% |
| Homecare Settings | 23% |
| Long-Term Care Centers | 15% |
| Ambulatory Surgical Centers | 6% |
| Specialty Clinics | 8% |
The Hospitals Segment Dominated the Market With 48% in 2025
The hospitals segment held a major revenue share of 48% of the therapeutic clinical nutrition market in 2025, driven by the management of the majority of acute and critical nutrition therapies. Increased surgical procedures also supported institutional demand. Advanced nutrition support teams also expanded their clinical adoption.
The homecare settings segment held the second-largest share of 23% of the market in 2025 and is expected to expand rapidly with a CAGR of 8.90% during the forecast period, due to a shift towards home-based care, which increases therapeutic nutrition use. Portable feeding systems also improve home administration convenience. They also help in reducing hospitalization costs, promoting their acceptance rates.
The long-term care centers segment held 15% of the therapeutic clinical nutrition market share in 2025, as a rise in the elderly population increases demand for continuous nutritional care. Facilities integrate disease-specific nutrition programs, promoting their use. Chronic disease prevalence also supports higher utilization rates.
The specialty clinics segment held 8% of the market share in 2025, due to specialized disease management, which increases targeted nutrition therapy use. Oncology and gastroenterology clinics are also expanding nutritional support programs. Personalized nutrition recommendations also improve their adoption rates.
| Segment | Share 2025 (%) |
| Proteins | 34% |
| Carbohydrates | 21% |
| Lipids | 17% |
| Vitamins & Minerals | 19% |
| Probiotics & Prebiotics | 9% |
The Proteins Segment Dominated the Market With 34% in 2025
The proteins segment contributed the biggest revenue share of 34% of the therapeutic clinical nutrition market in 2025, due to a rise in the high-protein formulations that support muscle preservation and recovery. Oncology and geriatric patients require increased protein intake, which promotes their use. Innovation in plant-based proteins also expanded product offerings.
The carbohydrates segment held the second-largest share of 21% of the market in 2025, as energy-support formulations remain essential in clinical nutrition. Fiber-enriched carbohydrate blends are also improving digestive health outcomes. Balanced nutrition protocols also maintain their stable demand.
The vitamins & minerals segment held 19% of the therapeutic clinical nutrition market share in 2025, due to micronutrient deficiencies, which increase supplementation requirements. Clinical protocols also emphasize immune and metabolic support. Preventive nutrition trends also support market growth.
The probiotics & prebiotics segment held 9% of the market share in 2025 and is expected to gain the highest share with a CAGR of 9.10% during the forecast period, as increasing gut microbiome research accelerates therapeutic nutrition innovation. Digestive health awareness is also increasing probiotic formulation adoption. Personalized nutrition trends also support microbiome-focused product development.
North America dominated the therapeutic clinical nutrition market with 38% in 2025, due to an advanced healthcare infrastructure, which supported widespread therapeutic nutrition adoption. High chronic disease prevalence also increased nutritional intervention demand. Strong reimbursement systems also enhanced market penetration.
U.S. Market Trends
The large aging population in the U.S. is increasing the demand for medical nutrition requirements. High cancer and diabetes prevalence is also supporting the use of disease-specific formulations. Home care nutrition adoption also continues its expansion.
Asia Pacific held 24% share of the therapeutic clinical nutrition market in 2025 and is expected to grow at the fastest CAGR of 9.10% during the forecast period, due to rapid healthcare infrastructure development, which accelerates clinical nutrition adoption. A large patient population is also increasing its use for chronic disease management. Rising healthcare expenditure is also supporting advanced nutrition therapies, promoting the market growth.
India Market Trends
Increasing malnutrition and diabetes prevalence across India is driving the demand for therapeutic nutrition. Expanding private healthcare infrastructure is also driving their adoption rates. Rising awareness of clinical nutrition is also promoting its use and innovations.
R&D
Clinical Trials and Regulatory Approvals
Patient Support and Services
| Companies | Headquarters | Therapeutic Clinical Nutrition Products |
| Abbott Nutrition | Abbott Park, U.S. | Ensure, Glucerna, and Jevity |
| B. Braun SE | Melsungen, Germany | Lipidem, Remune, and Nutricomp |
| Nestle Health Science | Vevey, Switzerland | Peptamen, Isosource, Resource, and Optifast |
| Ajinomoto Co. | Tokyo, Japan | PNTWIN and Cambrooke |
| Danone (Nutricia) | Paris, France | Fortisip, KetoCal, Neocate, and Souvenaid |
| Otsuka Holdings | Tokyo, Japan | Hinora and Racol-NF |
| Fresenius Kabi | Bad Homburg, Germany | Fresubin, Supportan, and Kabiven |
| Meji Holdings | Tokyo, Japan | Meji MeiBalance and Logipick |
| Baxter International | Deerfield, U.S. | Clinimix, Nutrineal, and Olimel |
| Reckitt (Mead Johnson) | Slough, UK | Enfamil, Enfaport, and PurAmino |
Strengths
Weaknesses
Opportunities
Threats
By Product Type
By Therapeutic Area
By End User
By Ingredient Type
By Application
By Route of Administration
By Age Group
By Distribution Channel
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
